Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s13048-018-0404-1 http://scihub22266oqcxt.onion/10.1186/s13048-018-0404-1 C5894219!5894219!29636080     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Ovarian+Res 2018 ; 11 (ä): ä Nephropedia Template TP {{tp|p=29636080|t=2018. Transparency in ovarian cancer clinical trial results: ClinicalTrials gov versus PubMed, Embase and Google scholar |pdf=|usr=}}{{29636080}} gab.com Text Transparency in ovarian cancer clinical trial results: ClinicalTrials gov versus PubMed, Embase and Google scholar JO: J Ovarian Res http://www.kidney.de/pget.php?&tw=1&pmid=29636080 #FOAvip Background: In recent years the question of the lack of transparency in clinical research has been debated by clinicians, researchers, citizens and their representatives, authors and publishers. This is particularly important for infrequent cancers such as ovarian cancer, where treatment still gives disappointing results in the majority of cases. Our aim was to assess the availability to the public of results in ClinicalTrials.gov, and the frequency of non-publication of results in ClinicalTrials.gov and in PubMed, Embase and Google Scholar. We collected all trials on ovarian cancer identified as ?completed status? in the ClinicalTrials.gov registry on 17 January 2017. We checked the availability of the results in ClinicalTrials.gov and systematically identified published manuscripts on results. Results: Out of 2725 trials on ovarian cancer identified, 752 were classified as ?completed status?. In those closed between 2008 and 2015, excluding phase I, the frequency of results in ClinicalTrials.gov was 35%. Of the 752 completed studies the frequency of published results in PubMed, Embase or Google Scholar ranged from 57.9% to 69.7% in the last years. Conclusions: These findings show a lack of transparency and credibility of research. Citizens or patients? representatives, with the medical community, should continuously support initiatives to improve the publication and dissemination of clinical study results. Twit Text FOAVip Transparency in ovarian cancer clinical trial results: ClinicalTrials gov versus PubMed, Embase and Google scholar ????J Ovarian Res http://www.kidney.de/pget.php?&tw=1&pmid=29636080 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29636080 #FOAvip English Wikipedia <ref>{{Cite pmid|29636080}}</ref> Transparency in ovarian cancer clinical trial results: ClinicalTrials gov versus PubMed, Embase and Google scholar #MMPMID29636080 Roberto A; Radrezza S; Mosconi P J Ovarian Res 2018[]; 11 (ä): ä PMID29636080show ga Background: In recent years the question of the lack of transparency in clinical research has been debated by clinicians, researchers, citizens and their representatives, authors and publishers. This is particularly important for infrequent cancers such as ovarian cancer, where treatment still gives disappointing results in the majority of cases. Our aim was to assess the availability to the public of results in ClinicalTrials.gov, and the frequency of non-publication of results in ClinicalTrials.gov and in PubMed, Embase and Google Scholar. We collected all trials on ovarian cancer identified as ?completed status? in the ClinicalTrials.gov registry on 17 January 2017. We checked the availability of the results in ClinicalTrials.gov and systematically identified published manuscripts on results. Results: Out of 2725 trials on ovarian cancer identified, 752 were classified as ?completed status?. In those closed between 2008 and 2015, excluding phase I, the frequency of results in ClinicalTrials.gov was 35%. Of the 752 completed studies the frequency of published results in PubMed, Embase or Google Scholar ranged from 57.9% to 69.7% in the last years. Conclusions: These findings show a lack of transparency and credibility of research. Citizens or patients? representatives, with the medical community, should continuously support initiatives to improve the publication and dissemination of clinical study results. äTransparency in ovarian cancer clinical trial results: ClinicalTrials (epmc).pdf DeepDyve Pubget Overpricing